Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir Add-on in Korean T2DM
NCT00455858Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2007
- Primary completion
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Primary endpoint: Change in Glycosylated Haemoglobin A1c at 20 weeks. Started Nov 2007; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00455858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455858.